• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.08% Nasdaq Up 0.40%

    Hemispherx Biopharma, Inc. (HEB)

    -NYSE MKT
    0.19 Up 0.01(3.24%) 11:36AM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:0.19
    Open:0.18
    Bid:0.19 x 500
    Ask:0.19 x 1200
    1y Target Est:1.45
    Beta:-0.33
    Next Earnings Date:N/A
    Day's Range:0.18 - 0.19
    52wk Range:0.17 - 0.40
    Volume:152,498
    Avg Vol (3m):1,321,400
    Market Cap:46.33M
    P/E (ttm):N/A
    EPS (ttm):-0.09
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for HEB

    Comparison

    Symbol% ChgMkt Cap
    HEBUp 3.24%46.33M
    GILDUp 0.42%174.00B
    MRKUp 1.25%167.39B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):274.03
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :N/A
    Quarterly EPS Est (Dec-14) :N/A
    Mean Recommendation*:1.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Hemispherx Biopharma, Inc., a specialty pharmaceutical company, engages in the clinical development of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders in the Un... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback